AstraZeneca PLC
AstraZeneca PLC
AstraZeneca PLC
AZN
AZN
NYSE
Health Technology
Pharmaceuticals: Major
165.41
USD
-1.27
-0.76%
Closed: 10-16 20:00 (UTC+0)
164.21
USD
-1.2
-0.73%
After Hours: 10-17 00:00 (UTC+0)

AZN Key Statistics

High
167.18
Open
166.97
Volume
3.46M
Low
164.37
Prev. Close
166.68
Trading Value
573.32M
52-Week High
212.71
Relative Volume
1.259
Amplitude (%)
1.69%
52-Week Low
153.41
Turnover Rate
--
Market Cap
256.53B
P/E Ratio (TTM)
--
P/E Ratio (Annual)
25.062
P/B Ratio
18.96
P/S Ratio
10.66
Earnings Per Share (EPS)
--
Dividend (TTM)
2.283
Dividend Yield
--
Shares Outstanding
--
Currency Unit
USD

AZN Price Performance

7 day
30 day
90 day
180 day
Year to date
1 Year
AZN Money Flow Distribution
AZN Daily Short Sale Volume
AZN Short Interest History
As of 2026-10-18, the AstraZeneca PLC (AZN) stock price today is 165.41. Based on this price, the company has a market capitalization of $256.53B, with a P/E ratio of --. On 2026-10-18, AZN traded between 164.37 and 167.18. Today’s stock price is 0.63% above the daily low and 1.06% below the daily high, placing AZN in the lower range of its most recent trading range. Trading volume currently stands at 3.46M, compared with an average daily volume of 2.75M. This suggests that trading activity is above its usual level than usual. Over the past year, AstraZeneca PLC shares have traded between 153.41 and 212.71. At today’s price, AZN is 7.82% above its 52-week low and 22.24% below its 52-week high.
Company Name
AstraZeneca PLC
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
NYSE
Number of Employees
96,100
Lot Size
100
Official Website
Currency Unit
USD
AstraZeneca PLC (AZN) is a global biopharmaceutical company formed in 1999 through the merger of Sweden's Astra and the United Kingdom's Zeneca. It sells branded medicines in oncology, which contributes more than 40% of revenue; cardiovascular, renal, and metabolic diseases, which contribute more than 20%; rare diseases, about 16%; and respiratory and immunology, about 15%. Most sales come from international markets, while the United States accounts for close to one-third of total sales.

AZN FAQ